Changes in Hong Kong stocks | Xianruida Medical-B (06669) rose nearly 5% in the afternoon, and the company continues to deepen strategic cooperation with Boston Scientific

The Zhitong Finance App learned that Xianruida Medical-B (06669) rose nearly 5% in the afternoon. As of press release, it had risen 4.36% to HK$13.17, with a turnover of HK$3.041,600.

According to the news, Xianruida signed a general cooperation agreement and a general service agreement with Boston Scientific's subsidiary. Following the signing of the first contract in 2023, the two sides will continue to deepen strategic cooperation, continue and expand their previous successful partnership, and jointly agree on a series of cooperation between the two sides in the fields of global commercialization of products, product manufacturing services, and product development within the next three years. Among them, at the sales level, the maximum transaction amount for Boston Scientific's procurement of Xianruida products for global sales in the next three years is a total of 170 million US dollars.